Knee Joint Injection: Difference between revisions

From WikiMSK

No edit summary
No edit summary
Line 2: Line 2:
{{procedure
{{procedure
|indication=
|indication=
|syringe=
|syringe=10mL
|needle=
|needle=20-27g
|steroid=
|injectate=Steroid, hyaluronic acid, PRP, dextrose
|injectate=
|steroid=0.5-2mL of steroid (e.g. 20-40mg triamcinolone)
|local=
|local=5-10mL of 1% lidocaine or 0.25% to 0.5% bupivacaine
|volume=
|volume=5-10mL
}}
}}


Line 36: Line 36:
*Clean the skin
*Clean the skin
*Draw up the injectate mixture.
*Draw up the injectate mixture.
*
*Optional infiltration of skin with 3-5mL local anaesthetic with 27-30g needle.
Use a combination of 5 to 10 ml of 1% lidocaine or 0.25% to 0.5% bupivacaine mixed with 0.5 to 2 ml of the selected steroid (20-80 mg of methylprednisolone acetate, 20-40 mg of triamcinolone acetate or 6-12 mg of betamethasone acetate/phosphate).
*Use a 20-27 gauge 1 inch needle on a 10 ml syringe to enter the joint.
Hyaluronic acid injections come in 2 ml prefilled syringes given once per week for 5 weeks for Hyalgan and once per week for 3 weeks for Synvisc.
*Approach
**Lateral: Enter the skin 1 cm superior and 1 cm lateral to the superior lateral aspect of the patella; direct the needle at a 45° angle, tilting below the patella, and aim toward the middle of the medial side of the joint
**Medial: Enter the medial aspect of the knee at the middle of the patella, aiming toward the lateral midpole.
**Anterior: The patient's knee should be flexed 90°; keeping the needle parallel to the tibial plateau, enter just medial or lateral to the patellar tendon
*May feel a "pop" when penetrating the joint capsule. Flow of the injection should not meet resistance.
*Change the path of the needle slightly if injecting the medication is difficult; the needle may be within a fat pad or thick synovium.
*Redirect or withdraw the needle if severe pain occurs; the needle may be hitting the cartilaginous surface.
*Apply a bandage after withdrawing the needle.


==Complications==
==Complications==
Repetitive intra-articular corticosteroid injections may cause accelerated cartilage loss. McAlindon evaluated triamcinolone vs saline repeated every 12 weeks for 2 years in 141 patients with knee osteoarthritis. The steroid group had greater cartilage loss (-0.21 mm vs -0.10mm), and no significant difference in pain. There was a small increase in HbA1c levels in the steroid group. The steroid group had 5 complications, and the saline group had 3.<ref>{{#pmid:28510679}}</ref>
Repetitive intra-articular corticosteroid injections may cause accelerated cartilage loss. McAlindon evaluated triamcinolone vs saline repeated every 12 weeks for 2 years in 141 patients with knee osteoarthritis. The steroid group had greater cartilage loss (-0.21 mm vs -0.10mm), and no significant difference in pain. There was a small increase in HbA1c levels in the steroid group. The steroid group had 5 complications, and the saline group had 3.<ref>{{#pmid:28510679}}</ref>
Other complications include bleeding, infection (1:10,000), postinjection flare (1%-2%), no response, non-sustained response, temporary glucose elevated. Allergic reactions are rare.
Specific to hyaluronic acid is that it can more frequently cause pain and can cause a large joint effusion, rash, and itching.


==Aftercare==
==Aftercare==
Rest the knee, avoid strenuous activity for 48 hours, shower/bathe as normal. Post-injection flares can be treated with ice and NSAIDs. Safety netting for injection.


==Videos==
==Videos==
Line 55: Line 67:
{{Reliable sources|synonym1=""|synonym2=""|synonym3=""}}
{{Reliable sources|synonym1=""|synonym2=""|synonym3=""}}


[[Category:Infobox Templates]]
[[Category:Infoboxes]]
[[Category:Infoboxes]]
[[Category:Knee & Leg Procedures]]
[[Category:Knee & Leg Procedures]]
[[Category:Stubs]]

Revision as of 14:26, 2 April 2021

This article is a stub.
Knee Joint Injection
Indication
Syringe 10mL
Needle 20-27g
Injectate Steroid, hyaluronic acid, PRP, dextrose
Steroid 0.5-2mL of steroid (e.g. 20-40mg triamcinolone)
Local 5-10mL of 1% lidocaine or 0.25% to 0.5% bupivacaine
Volume 5-10mL


Anatomy

Indications

Contraindications

Infection, uncontrolled coagulopathy, joint prosthesis, poor response to previous injections. Allergy to eggs or feathers is a relative contraindication to hyaluronic acid.

Pre-procedural Evaluation

Injectate

A variety of options exist for injectates - steroid, visco-supplementation, platelet rich plasma, stem cells, and dextrose prolotherapy.

Equipment

Technique

Ultrasound Guided

Fluoroscopy Guided

Landmark Guided

  • Protective gloves and use sterile technique.
  • Position: Lie supine with the knee slightly flexed, supported underneath with a rolled towel or cushion.
  • Palpate and identify the borders of the patella and mark the entry site
  • Clean the skin
  • Draw up the injectate mixture.
  • Optional infiltration of skin with 3-5mL local anaesthetic with 27-30g needle.
  • Use a 20-27 gauge 1 inch needle on a 10 ml syringe to enter the joint.
  • Approach
    • Lateral: Enter the skin 1 cm superior and 1 cm lateral to the superior lateral aspect of the patella; direct the needle at a 45° angle, tilting below the patella, and aim toward the middle of the medial side of the joint
    • Medial: Enter the medial aspect of the knee at the middle of the patella, aiming toward the lateral midpole.
    • Anterior: The patient's knee should be flexed 90°; keeping the needle parallel to the tibial plateau, enter just medial or lateral to the patellar tendon
  • May feel a "pop" when penetrating the joint capsule. Flow of the injection should not meet resistance.
  • Change the path of the needle slightly if injecting the medication is difficult; the needle may be within a fat pad or thick synovium.
  • Redirect or withdraw the needle if severe pain occurs; the needle may be hitting the cartilaginous surface.
  • Apply a bandage after withdrawing the needle.

Complications

Repetitive intra-articular corticosteroid injections may cause accelerated cartilage loss. McAlindon evaluated triamcinolone vs saline repeated every 12 weeks for 2 years in 141 patients with knee osteoarthritis. The steroid group had greater cartilage loss (-0.21 mm vs -0.10mm), and no significant difference in pain. There was a small increase in HbA1c levels in the steroid group. The steroid group had 5 complications, and the saline group had 3.[1]

Other complications include bleeding, infection (1:10,000), postinjection flare (1%-2%), no response, non-sustained response, temporary glucose elevated. Allergic reactions are rare.

Specific to hyaluronic acid is that it can more frequently cause pain and can cause a large joint effusion, rash, and itching.

Aftercare

Rest the knee, avoid strenuous activity for 48 hours, shower/bathe as normal. Post-injection flares can be treated with ice and NSAIDs. Safety netting for injection.

Videos

See Also

External Links

References

  1. McAlindon et al.. Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial. JAMA 2017. 317:1967-1975. PMID: 28510679. DOI. Full Text.

Literature Review